Press Room

Filter by year:
January 8, 2020

NorthSea Therapeutics Announces US $40 Million Series B Financing to Complete Phase IIb ICONA study in NASH and to Advance Two Additional SEFAs into the Clinic

Two new US investors; lead investor, venBio Partners and Sofinnova Investments, join syndicate of existing investors Richard Gaster, M.D., Ph.D., Principal at venBio Partners, and Maha Katabi, Ph.D., CFA, Partner at Sofinnova Investments join the Board Proceeds will be used to progress the SEFA development pipeline: Completion of Phase 2b study of lead programme Icosabutate…

Read more
January 3, 2020

Hello world!

Welcome to WordPress. This is your first post. Edit or delete it, then start writing! The post Hello world! appeared first on Novadip.

Read more